Nirvana Life Sciences Statistics

Total Valuation

Nirvana Life Sciences has a market cap or net worth of CAD 3.62 million. The enterprise value is 3.63 million.

Market Cap	3.62M
Enterprise Value	3.63M

Important Dates

The last earnings date was Thursday, August 29, 2024.

Earnings Date	Aug 29, 2024
Ex-Dividend Date	n/a

Share Statistics

Nirvana Life Sciences has 48.23 million shares outstanding. The number of shares has increased by 31.20% in one year.

Shares Outstanding	48.23M
Shares Change (YoY)	+31.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.28%
Owned by Institutions (%)	n/a
Float	33.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.96
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-139.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-197.82%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +87.50% in the last 52 weeks. The beta is 0.68, so Nirvana Life Sciences's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+87.50%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	93.33
Average Volume (20 Days)	5,301

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-956,890
Pretax Income	-1.23M
Net Income	-1.23M
EBITDA	-921,770
EBIT	-956,890
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 3,137 in cash and 23,624 in debt, giving a net cash position of -20,487 or -0.00 per share.

Cash & Cash Equivalents	3,137
Total Debt	23,624
Net Cash	-20,487
Net Cash Per Share	-0.00
Equity (Book Value)	-816,998
Book Value Per Share	-0.02
Working Capital	-979,789

Full Balance Sheet

Cash Flow

Operating Cash Flow	-252,662
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nirvana Life Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.20%
Shareholder Yield	-31.20%
Earnings Yield	-37.96%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a